Form 8-K - Current report:
SEC Accession No. 0001558370-16-007399
Filing Date
2016-08-04
Accepted
2016-08-04 16:13:41
Documents
2
Period of Report
2016-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adms-20160804x8k.htm 8-K 35648
2 EX-99.1 adms-20160804ex991163e7b.htm EX-99.1 282448
  Complete submission text file 0001558370-16-007399.txt   319317
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 161807581
SIC: 2834 Pharmaceutical Preparations